Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2007
11/29/2007WO2007006594A3 Reactive azo dyes, methods for the production thereof and their use
11/29/2007WO2006138572A3 Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
11/29/2007US20070276168 Method For Preparation Of A Fluoroaromatic Compound From An Aminoaromatic Compound
11/29/2007US20070276143 Method for producing optically active compound
11/29/2007US20070276140 Chiral 1,8-Diarylnaphthalenes, Methods of Making Them, and Their Use as Sensors
11/29/2007US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007US20070276015 Crystal modification of torasemide
11/29/2007US20070275985 Triazolopyrimidines
11/29/2007US20070275980 Amide Derivatives, Process For Preparation Thereof And Use Thereof As Insecticide
11/29/2007US20070275959 Carbamoyl Esters That Inhibit Cholinesterase And Release Pharmacologically Active Agents
11/29/2007US20070275956 Novel Heterocyclic Compounds
11/29/2007US20070275953 2-Pyridinone Derivatives, Having Hiv Inhibiting Properties
11/29/2007US20070275950 2-Phenylpyridine Derivative
11/29/2007US20070275932 Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
11/29/2007US20070275911 Targeted Drug-Formaldehyde Conjugates and Methods of Making and Using the Same
11/29/2007US20070275090 Ionic Uv-A Sunscreens and Compositions Containing Them
11/29/2007DE202007011042U1 Polymorphe Formen von Flupirtinmaleat Polymorphic forms of flupirtine maleate
11/29/2007CA2653062A1 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament
11/29/2007CA2652440A1 Composition for diagnosis of amyloid-related disease
11/29/2007CA2652117A1 Therapeutic fluoroethyl ureas
11/29/2007CA2651153A1 Antidiabetic bicyclic compounds
11/29/2007CA2650795A1 Novel microbiocides
11/29/2007CA2649196A1 New hydroxyphenyl derivatives and biological applications thereof
11/28/2007EP1859798A1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
11/28/2007EP1858869A1 Acylated piperidines as glycine transporter inhibitors
11/28/2007EP1858854A1 Pyridine-2-carboxamide derivatives as mglur5 antagonists
11/28/2007EP1858853A2 Novel pyridine derivatives as potassium ion channel openers
11/28/2007EP1858852A1 Heteroarylsulfonyl stilbenes as 5-ht2a antagonists
11/28/2007EP1761516B1 2, 4, 5, 6-substituted pyrimidines, method for the production and use thereof for combating parasitic fungi
11/28/2007EP1663978B1 Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
11/28/2007EP1654225A4 Melanin concentrating hormone receptor antagonists
11/28/2007EP1474388B1 Astaxanthin esters
11/28/2007EP1406613B1 Organic nitratederivatives for the treatment of atherosclerosis and vascular diseases
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007EP1056723B1 2-pyridylmethylamine derivatives useful as fungicides
11/28/2007CN101080392A Piperazinyl pyridine derivatives as anti-obesity agents
11/28/2007CN101080391A Process for the preparation of a 2-pyridylethylcarboxamide derivative
11/28/2007CN101080390A Process for the preparation of a 2-ethylaminopyridine derivative
11/28/2007CN101080389A Indane amides with antiproliferative activity
11/28/2007CN101078129A Formiate ion liquid compound and its preparing method and application
11/28/2007CN101077875A Boronic ester and acid compounds, synthesis and uses
11/28/2007CN101077867A Bis-aryl sulfonamides
11/28/2007CN100351257C Method for producing pyridoxine or an acid addition salt thereof
11/28/2007CN100351237C Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine
11/27/2007US7301031 Methods for producing hydroxy amino acids, esters, and derivatives thereof
11/27/2007US7301029 Drugs; agricultural chemicals; electrography photosensitive materials
11/27/2007US7301028 Mitotic kinesin inhibitors
11/27/2007US7301023 Immunosuppressants; grafting of organs; rheumatic diseases
11/27/2007US7301021 Substituted imidazole compounds
11/27/2007US7300956 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
11/27/2007US7300948 Useful for the manufacture of a medicament for treating HIV infection in a human infected by HIV. The compounds are potent inhibitors of wild-type (WT) and double mutant strains of HIV-1 RT, particularly the double mutant K103N/Y181C; benzophenone derivatives
11/27/2007US7300941 Non-imidazole compounds
11/27/2007US7300937 Derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
11/27/2007US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
11/27/2007US7300917 Remedy for chronic disease
11/27/2007CA2299710C Aryloxyaniline derivatives
11/22/2007WO2007134038A2 Salt forms of (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine
11/22/2007WO2007134034A1 Polymorph forms of (2s) - (4e) -n-methyl-5- (3-isopropoxypyridin) yl] -4-penten-2-amine for the treatment of central nervous system disorders
11/22/2007WO2007132948A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132478A2 Process for the preparation of pure risedronic acid or salts
11/22/2007WO2007132307A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
11/22/2007WO2007095229A3 Insecticidal n-substituted (6-haloalkylpyridin-3-yl)alkyl sulfoximines
11/22/2007WO2007089669A3 Processes for the preparation of compounds which modulate cell proliferation
11/22/2007WO2007062314A3 Heterocyclic cetp inhibitors
11/22/2007WO2006121719A3 Soluble epoxide hydrolase inhibitors and methods of using same
11/22/2007US20070270482 Cytotoxic Agents Comprising New C-2 Modified Taxanes
11/22/2007US20070270472 Amino, Amino Acid or Peptide Conjugates of Retinoic Acid
11/22/2007US20070270469 e.g. 4-(5-{(1R)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4H-1,2,4-triazol-3-yl)pyridine hydrochloride; glutamate mGluR5 receptor modulator; antidepressant, anxiolytic, analgesic agent; neurodegenerative disorder
11/22/2007US20070270468 e.g. 4-(5-{(1R)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4H-1,2,4-triazol-3-yl)pyridine hydrochloride; glutamate mGluR5 receptor modulator; antidepressant, anxiolytic, analgesic agent; neurodegenerative disorder
11/22/2007US20070270441 Combination
11/22/2007US20070270421 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
11/22/2007US20070270407 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
11/22/2007US20070267968 Electronic devices made with electron transport and/or anti-quenching layers
11/22/2007DE10297577B4 Zinkkomplexe, die fähig sind, Substanzen, die anionische Substituenten haben, abzufangen Zinc complexes, which are capable of substances having anionic substituents trap,
11/22/2007CA2651629A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
11/22/2007CA2649961A1 Polymorph forms of (2s) - (4e) -n-methyl-5- (3-isopropoxypyridin) yl] -4-penten-2-amine for the treatment of central nervous system disorders
11/21/2007EP1857113A2 Method and materials for treating asthma
11/21/2007EP1857104A1 Use of cinnamoyl compound
11/21/2007EP1856091A1 Compounds for stabilizing factor vii polypeptide formulations
11/21/2007EP1856077A1 Piperazine derivatives as glyt1 inhibitors
11/21/2007EP1856076A1 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
11/21/2007EP1856063A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
11/21/2007EP1856056A1 Phenoxy benzamide compounds with utility in the treatment of type 2 diabetes and obesity
11/21/2007EP1856053A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
11/21/2007EP1856052A2 Nk1 antagonists
11/21/2007EP1856031A1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
11/21/2007EP1856030A2 Structural analogues of avenanthramides, their use in compositions useful in the treatment of dermatological disorders
11/21/2007EP1572653B1 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants
11/21/2007EP1421062B1 Novel cyclohexyl sulphones
11/21/2007CN101076524A Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
11/21/2007CN101076518A 5-amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropxy)benzyl]-8-methylnonanamides
11/21/2007CN101076336A Novel curcumin analogues and uses thereof
11/21/2007CN101074242A Cells accumulation for sphosphonate analogs of HIV protease inhibitor compound and the same compound
11/21/2007CN101074211A Process for treating high-purity pyridine solution
11/21/2007CN101073782A 4-dimethy-pyridine organic small-molecular catalyst containing central chiral functional base and its production
11/21/2007CN100349862C 大麻素受体配体 Cannabinoid receptor ligands
11/21/2007CN100349856C Propionic acid derivatives and their use as hPPARs activators
11/20/2007US7297820 Thio substituted stilbene amines; inhibiting the aggregation of amyloid proteins
11/20/2007US7297808 Statin derivatives
11/20/2007US7297806 Ethylene oligomerization catalyst comprising an iron complex of a 2,6-bis(1-(phenylimino)ethyl)pyridine ligand of given formula with a Lewis acid such as methylalumoxane; forms alpha-olefins of formula H-(CH2-CH2)q-CH=CH2 q=1-18
1 ... 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 ... 633